Abstract
Maintenance of glucose balance in mammals depends on the production of insulin by the β-cells of the pancreas, in response to raised concentrations of blood glucose. In humans suffering from non-insulindependent diabetes (NIDDM), β-cell failure follows chronic resistance to insulin-stimulated glucose uptake and causes the development of hyperglycaemia1. NIDDM shows a polygenic inheritance pattern in most cases2: defined genetic defects that have little effect on their own, in combination induce diabetes by epistatic interactions3. Here we show that mice heterozygous for the gene pdx-1, which encodes a transcription factor for the insulin gene and regulates pancreatic development, have impaired glucose tolerance. This pancreatic nuclear regulatory factor is required for glucose homeostasis even when the pancreas is morphologically normal.
Main
The pdx-1 -encoded homeodomain protein in mammals (STF-1, IPF-1, IDX-1)4,5,6 was isolated as a transcriptional regulator of insulin and somatostatin7,8,9. The protein was first detected in the embryonic pancreatic and duodenal endoderm. But in the pancreas, pdx-1 expression becomes progressively restricted to islets, where it is produced in more than 90% of β-cells, and in substantially fewer δ-cells (15%) and α-cells (3%)10,11.
Mice that are heterozygous (+/−) for pdx-1 develop normally, but in pdx-1 homozygotes (−/−), the branching outgrowth of the pancreas that usually occurs is arrested at an early stage11,12. The relevance of these findings is underscored by a description of a human phenotype lacking a pancreas and associated with a mutation in the pdx-1 gene13,14. Maturity-onset diabetes occurred in humans heterozygous for this mutation13; this prompted us to examine whether pdx-1 is important for glucose homeostasis in an adult mouse model.
We fasted pdx-1 wild-type and +/− mice for 14-16 hours and injected them intraperitoneally with 20% glucose (2 grams per kilogram body weight). The blood glucose levels of the wild type underwent a threefold increase within 15 minutes but returned to baseline two hours later (Fig. 1a). By contrast, +/− mice showed a 7-10-tenfold increase in blood glucose levels after 30 minutes. These mice remained hyperglycaemic even after 2 hours (Fig. 1a).
The levels of plasma insulin following glucose administration (not shown) did not differ appreciably between wild-type and +/− animals, but these insulin levels were inappropriately low for the degree of hyperglycaemia observed in the +/− mice.
In histological evaluation, the pancreatic islets from the +/− mice appeared somewhat smaller, with a thicker mantle devoid of β-cells, than those of the wild type (Fig. 1b). The mass of β-cells was reduced, but to an extent that was not significant (wild-type mice: 2.80 milligrams ± 0.44; n = 8; +/− mice: 1.76 milligrams ± 0.13; n = 4). However, the mass of non-β-cells was almost doubled in +/− compared with wild-type mice (wild-type mice: 0.47 mg ± 0.06; +/− mice: 0.82 mg ± 0.10). This suggests that a deficiency in the pdx-1 gene may skew the islet cell lineages towards developing into non-β cells.
Our results support the idea that, as well as acting as a regulatory protein for pancreatic development, the protein encoded by pdx-1 is required for glucose homeostasis in the adult pancreas. Thus a deficiency in pdx-1 may predispose certain individuals to the development of late-onset diabetes, particularly in the context of other genetic mutations within the insulin-signalling cascade.
References
Ciaraldi, T. P., Abrams, L., Nikoulina, S., Mudaliar, S. & Henry, R. R. J. Clin. Invest. 96, 2820–2827 (1995).
Sacks, D. B. & McDonald, J. M. Am. J. Clin. Pathol. 105, 149–156 (1996).
Bruning, J.et al. Cell 88, 561–572 (1997).
Leonard, J.et al. Mol. Endocrinol. 7, 1275–1283 (1993).
Miller, C. P., McGhee, R. E. J & Habener, J. F. EMBO J. 13, 1145–1156 (1994).
Ohlsson, H., Karlsson, K. & Edlund, T. EMBO J. 12, 4251–4259 (1993).
Peers, B., Leonard, J., Sharma, S., Teitelman, G. & Montminy, M. R. Mol. Endocrinol. 8, 1798–1806 (1994).
Peers, B., Sharma, S., Johnson, T., Kamps, M. & Montminy, M. Mol. Cell. Biol. 15, 7091–7097 (1995).
Serup, P.et al. Biochem. J. 310, 997–1003 (1995).
Guz, Y.et al. Development 121, 11–18 (1995).
Offield, M. F.et al. Development 122, 983–995 (1996).
Jonsson, J., Carlsson, L., Edlund, T. & Edlund, H. Nature 371, 606–609 (1994).
Stoffers, D., Zinkin, N. T., Stanojevic, V., Clarke, W. L. & Habener, J. F. Nature Genet. 15, 106–110 (1997).
Stoffers, D. A., Ferrer, J., Clarke, W. J. & Habener, J. F. Nature Genet. 17, 138–139 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dutta, S., Bonner-Weir, S., Montminy, M. et al. Regulatory factor linked to late-onset diabetes?. Nature 392, 560 (1998). https://doi.org/10.1038/33311
Issue Date:
DOI: https://doi.org/10.1038/33311
This article is cited by
-
Therapeutic potential of mesenchymal stem cells in treating both types of diabetes mellitus and associated diseases
Journal of Diabetes & Metabolic Disorders (2020)
-
Regulation of pancreatic β-cell function and mass dynamics by prostaglandin signaling
Journal of Cell Communication and Signaling (2017)
-
Diabetes Caused by Elastase-Cre-Mediated Pdx1 Inactivation in Mice
Scientific Reports (2016)
-
Pancreatic regeneration: basic research and gene regulation
Surgery Today (2016)
-
Uncovering the mechanisms of beta-cell neogenesis and maturation toward development of a regenerative therapy for diabetes
Diabetology International (2015)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.